Based on recent data, Esperion Therapeutics, Inc. (ESPR) shows an Average True Range (ATR) of 0.22 and an Enterprise Value of 821.69M. Its average trading volume over the past 3 months is 5.67M, indicating liquidity. These fundamental metrics provide insight into ESPR's underlying financial health and market activity.
| ATR | 0.22 |
| Enterprise Value | 821.69M |
| Avg Vol (3 Months) | 5.67M |
| Avg Vol (10 Days) | 3.56M |
Esperion Therapeutics, Inc. (ESPR) technical indicators as of February 11, 2026: the SMA 20 is 3.1%, SMA 50 at -6.04%, and SMA 200 at 45.27%. The RSI 14 value is 49.1, suggesting its current momentum. These technical analysis signals help assess ESPR's price trends and potential future movements.
| SMA 20 | 3.1% |
| SMA 50 | -6.04% |
| SMA 200 | 45.27% |
| RSI 14 | 49.1 |
Esperion Therapeutics, Inc. (ESPR) stock performance overview as of February 11, 2026: The 52-week high is $4.18 (currently -18.8% below), and the 52-week low is $0.693 (currently 389.53% above). Over the past year, ESPR's performance is 27.88%, compared to the S&P 500's 8.87% change.
| 52-Week High | 4.18 |
| 52-Week High Chg | -18.80% |
| 52-Week Low | 0.6925 |
| 52-Week Low Chg | +389.53% |
| S&P 500 52-Week Chg | 8.87% |
According to market data, Esperion Therapeutics, Inc. (ESPR) stock's recent performance metrics show that over the last month, ESPR is -20.82%, with a Year-to-Date (YTD) performance of -21.89%. Over the past year, the stock has seen a 27.88% change. These figures summarize ESPR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 3.54 | 3.91 | 4.18 | 4.18 | 4.18 | 4.18 |
| Low | 3.16 | 2.86 | 2.49 | 1.74 | 0.6925 | 2.86 |
| Performance | -18.59% | -20.82% | +5.09% | +151.30% | +27.88% | -21.89% |
According to current financial data, ESPR stock's P/E (TTM) ratio is -6.32, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for ESPR, including P/S (2.20), P/B (-1.48), and P/FCF (-7.15), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | ESPR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -6.32 | -1.23 | 13.14 | 32.59 |
| P/S (TTM) | 2.2 | 3.71 | 6.11 | 5.98 |
| P/B (TTM) | -1.48 | 0.2 | 22.43 | 5.42 |
| P/FCF (TTM) | -7.15 | -7.44 | -2.53 | 31.77 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep